• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Amarin Corp (AMRN)

American Depository Receipt
Sell: $0.865|Buy: $0.885|Change: 0.01 (-1.43%)

Open 

$0.87

Previous close 

$0.8718

Trade high 

$0.8858

Volume 

1,024,891

Year high 

$1.49

Year low 

$0.65

Dividend yield 

-

Market capitalisation 

$344.88 mn

P/E ratio 

67.11

ISIN 

US0231112063

This share can be held in a Dealing accountSIPP

Share price

Performance 19/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Amarin Corp- 1.43
More...

Company profile

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.